Abstract
Our study demonstrates that severity scores do not correlate well with the impact that localized epidermolysis bullosa simplex (EBS) has on quality of life. There is a paucity of literature exploring correlations between disease severity and patient-reported outcome measures in EB. Both the Birmingham EB Severity (BEBS) score and EB Disease Activity and Severity Index (EBDASI) consist of weighted factors including body surface area, scalp, mucous membrane, nail and systemic involvement, as well as complications of longstanding disease such as cutaneous squamous cell carcinoma, which is more commonly seen in recessive dystrophic EB. Current scoring systems fail to account for the palmoplantar blistering and keratoderma which is the most significant source of morbidity in the EBS cohort.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
